Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus

Alessandra Vitelli, Mary R. Quirion(Center for Biologics Evaluation and Research), Chia-Yun Lo(Center for Biologics Evaluation and Research), Julia A. Misplon(Center for Biologics Evaluation and Research), Agnieszka Grabowska, Angiolo Pierantoni, Virginia Ammendola, Graeme E. Price(Center for Biologics Evaluation and Research), Mark R. Soboleski(Center for Biologics Evaluation and Research), Riccardo Cortese, Stefano Colloca, Alfredo Nicosia(University of Naples Federico II), Suzanne L. Epstein(Center for Biologics Evaluation and Research)
PLoS ONE
March 11, 2013
Cited by 49Open Access
Full Text

Abstract

Among approximately 1000 adenoviruses from chimpanzees and bonobos studied recently, the Pan Adenovirus type 3 (PanAd3, isolated from a bonobo, Pan paniscus) has one of the best profiles for a vaccine vector, combining potent transgene immunogenicity with minimal pre-existing immunity in the human population. In this study, we inserted into a replication defective PanAd3 a transgene expressing a fusion protein of conserved influenza antigens nucleoprotein (NP) and matrix 1 (M1). We then studied antibody and T cell responses as well as protection from challenge infection in a mouse model. A single intranasal administration of PanAd3-NPM1 vaccine induced strong antibody and T cell responses, and protected against high dose lethal influenza virus challenge. Thus PanAd3 is a promising candidate vector for vaccines, including universal influenza vaccines.


Related Papers

No related papers found

Powered by citation graph analysis